Eden vs Gala GLP-1 for weight loss
Eden and Gala GLP-1 side by side: what each costs as your dose rises, which medications each prescribes, and the terms behind the price.
By the RxLineup editorial team · Fact-checked against provider sites and FDA labels · Updated
Only providers that pay us appear in our rankings and reviews, and we’re paid when you sign up through our links. How we make money
- Safety: GLP-1 medications carry a boxed warning for thyroid C-cell tumors. Read before you start
Higher score
Eden
Rated 9.1 out of 10, Excellent
From $99/mo
Tirzepatide $129/mo
Gala GLP-1
Rated 8.8 out of 10, Excellent
From $129/mo
Tirzepatide $179/mo
The verdict
Eden is $30 a month cheaper for compounded semaglutide ($99/mo vs $129/mo); Eden is $50 a month cheaper for compounded tirzepatide ($129/mo vs $179/mo). Only Eden offers Wegovy, Zepbound and Mounjaro. Eden scores higher overall (9.1 vs 8.8), with its widest lead on price and value (9.3 vs 8.8).
Choose Eden if…
You want compounded semaglutide for $99/mo, compounded tirzepatide for $129/mo and the option of Wegovy, Zepbound or Mounjaro.
Choose Gala GLP-1 if…
You want Ozempic for $1,299/mo and a better experience score (9.5 vs 9.0).
What’s different
The six places where Eden and Gala GLP-1 differ for weight loss, from the prices and terms each publishes.
| Difference | Eden | Gala GLP-1 |
|---|---|---|
| Compounded semaglutide | $99/mo | $129/mo |
| Compounded tirzepatide | $129/mo | $179/mo |
| Ozempic | $1,498/mo | $1,299/mo |
| Wegovy | $1,794/mo | Not offered |
| Zepbound | $1,498/mo | Not offered |
| Mounjaro | $1,498/mo | Not offered |
Head to head
| Feature | Eden review | Gala GLP-1 review |
|---|---|---|
| Overall score | 9.1/10 Higher | 8.8/10 |
| Starting price | $99/mo Lower | $129/mo |
| Compounded semaglutide | $99/mo Lower | $129/mo |
| Compounded tirzepatide | $129/mo Lower | $179/mo |
| Brand-name options | Wegovy, Ozempic, Zepbound, Mounjaro | Ozempic |
| Same price at every dose | Yes | Yes |
| Membership | None | None |
| Insurance | Self-pay | Self-pay |
| Refunds | Weight Loss Warranty: follow your Eden plan for 6 months and, if you lose less than 15% of your body weight, you may qualify for your money back. Eligibility depends on plan adherence and required check-ins | Refund of remaining charges if you are medically disqualified |
| Availability | – | Licensed providers in all 50 states |
| Next step | Visit Eden for Eden (opens in a new tab) | Visit Gala GLP-1 for Gala GLP-1 (opens in a new tab) |
– Not published by the provider.
Scores compared
Both programs are scored out of 10 on the same five weighted criteria. How we rate
EdenGala GLP-1
-
Price & value 30%
-
Clinical care 25%
-
Medication options 20%
-
Transparency 15%
-
Experience 10%
Eden pros and cons
Strengths
- $99/mo semaglutide and $129/mo tirzepatide at every dose
- No membership fee or long-term contract on GLP-1 plans
- Weight Loss Warranty, and labwork when a provider orders it
- LegitScript seal; HSA/FSA eligible; free expedited shipping
Drawbacks
- Brand-name GLP-1s cost $1,399 to $1,695 a month plus a $99 membership
- Charges are non-refundable once filled, apart from the warranty
- Partner pharmacies other than Eden Pharmacy aren’t named
- No state list published
Gala GLP-1 pros and cons
Strengths
- Semaglutide from $129/mo, tirzepatide from $179/mo, all doses
- No membership fee; coaching and app included
- Free shipping, about 7 days to your door
- All 50 states
Drawbacks
- Prices differ across Gala pages ($129, $179, $199)
- Plan terms shown only at checkout
- No refund on cancellation unless medically disqualified
- Video is usually only for the first visit
Safety
One of these treatments carries an FDA boxed warning, the strongest warning on a label: GLP-1 medications.
- SemaglutideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- TirzepatideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- WegovyFDA-approved for long-term weight reduction (adults, and children 12 and older)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- OzempicFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ZepboundFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- MounjaroFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Not medical advice. A licensed clinician decides whether a treatment is right for you; read the full prescribing information before you start.
Not sure which program fits?
Answer five quick questions about budget, medication and insurance, and we’ll rank the programs for you. No email or sign-up needed.